Press Releases

Health News Posted on Friday, November 29, 2019

Premium Press Releases »

ElmediX Plans Series A Round Based on Strong Signals in a Clinical Study for Pancreatic Cancer Patients at the University Hospital Antwerp (Belgium)

A novel and innovative approach to treating metastasized cancer, starting with the very lethal grade 4 pancreatic cancer.  Earlier this year, scientists from Columbia University in New York demonstrated that the growth rate of pancreatic ...

Read More

Adalvo Secures First EU Generic Approval for Liraglutide Pre-Filled Pen

SAN ?WANN, Malta, June 13, 2024 (GLOBE NEWSWIRE) -- Adalvo announces the successful DCP approval for Liraglutide pre-filled pen, marking it as the first generic approval in the EU. As a bioequivalent version of Victoza ® pre-filled pen, ...

Read More

OBI Pharma Announces Phase 1/2 Study Initiation for OBI-992, a TROP2-Targeted Antibody-Drug Conjugate (ADC) for Cancer Therapy

TAIPEI, Taiwan, June 12, 2024 (GLOBE NEWSWIRE) -- OBI Pharma, a clinical-stage oncology company (4174.TWO), today announced the initiation of a Phase 1/2 clinical trial of OBI-992, an antibody-drug conjugate (ADC) targeting TROP2 (Trophoblast ...

Read More

PAP Therapy Reduces Hospitalizations by 31% and ER Visits by 23% for People with Obstructive Sleep Apnea and Comorbid Insomnia

SAN DIEGO, June 10, 2024 (GLOBE NEWSWIRE) -- In collaboration with leading medical researchers from around the world, ResMed (NYSE: RMD, ASX: RMD) presented 13 new clinical studies at SLEEP 2024, the annual joint meeting of the American Academy ...

Read More

Press Releases »

Vieworks to debut all new DR detectors at RSNA 2019

ANYANG, South Korea , Nov. 29, 2019 /PRNewswire/ -- Vieworks, a global leader in X-ray imaging solution, is showcasing the newest DR detector lineup featuring the advanced imaging technology at RSNA 2019 (South hall #1723) from 1 to 6 December ...

Read More

National Medical Products Administration (NMPA) Approves Chipscreen Bioscience's Chidamide (Epidaza) for Breast Cancer Indication

SHENZHEN, China , Nov. 29, 2019 /PRNewswire/ -- On November 29, 2019 , Shenzhen Chipscreen Biosciences Co., Ltd. (Chipscreen Biosciences, Stock Symbol: 688321.SH) announced that the company's lead innovative product Epidaza® (Chidamide), an ...

Read More

Orthopedic Foot & Ankle Specialist, Dr. Paul Kovatis Named 2019 NJ Top Doc

NJ Top Doc, Dr. Paul Kovatis continues to display expertise and leadership in the field of orthopedic foot and ankle surgery. SCOTCH PLAINS, N.J. , Nov. 29, 2019 /PRNewswire-PRWeb/ -- NJ Top Doc, Paul Kovatis , MD has been in private ...

Read More

Ascletis successfully obtained Pharmaceutical Trade License and GSP Certificate, formed a Complete Commercial Layout

HANGZHOU , China and SHAOXING, China , Nov. 28, 2019 /PRNewswire/ -- Ascletis Pharma Inc. (1672.HK), an innovative R&D driven, commercial-stage biotechnology company addressing unmet medical needs in therapeutic areas including anti-viral, ...

Read More

WuXi ATU and GeneMedicine Sign Development and Manufacturing Agreement for Oncolytic Virus Products

SHANGHAI and SEOUL, South Korea , Nov. 28, 2019 /PRNewswire/ -- WuXi ATU Co., Ltd., (WuXi ATU) - a subsidiary of WuXi AppTec, and GeneMedicine - a South Korea -based gene therapy biotechnology company, have formed a strategic partnership for ...

Read More

ISEA Announces New Board of Trustees, Naming Incoming Chair, Vice Chair and Treasurer

Chair Craig Wallentine says ISEA, "will stay focused on needs of end users to identify and implement safety innovations to protect more workers." ARLINGTON, Va. , Nov. 28, 2019 /PRNewswire-PRWeb/ -- Craig Wallentine , Global Business ...

Read More

AMF Concludes its Review of the Refinancing Transactions Completed by Liminal BioSciences in April 2019

LAVAL, QC , ROCKVILLE, MD and CAMBRIDGE, United Kingdom , Nov. 28, 2019 /PRNewswire/ - Liminal BioSciences Inc. (NASDAQ: LMNL) (TSX: LMNL) ( " Liminal BioSciences " or the "Company " ), a clinical-stage biopharmaceutical company focused on ...

Read More

Lumeca Health Expands Executive Team

Appoints Leah Olson-Friesen Chief Operating Officer REGINA , Nov. 28, 2019 /CNW/ - Lumeca Health, one of Canada's leading virtual healthcare platforms, is proud to announce the appointment of Leah Olson-Friesen to the role of Chief ...

Read More
More Press Releases

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.